» Authors » Matthew Cox

Matthew Cox

Explore the profile of Matthew Cox including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 311
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Poudel Y, Lo J, Norris D, Cox M, He L, Johnson W, et al.
ACS Med Chem Lett . 2025 Jan; 16(1):80-88. PMID: 39811121
Dual activation of the TLR7 and TLR8 pathways leads to the production of type I interferon and proinflammatory cytokines, resulting in efficient antigen presentation by dendritic cells to promote T-cell...
2.
Mir D, Cox M, Horrocks J, Ma Z, Rogers A
J Clin Med Sci . 2024 Sep; 8(2). PMID: 39323482
Dietary Restriction (DR) mitigates loss of proteostasis associated with aging that underlies neurodegenerative conditions including Alzheimer's disease and related dementias. Previously, we observed increased translational efficiency of certain FMRFamide-Like neuro-Peptide...
3.
Snow S, Mir D, Ma Z, Horrocks J, Cox M, Ruzga M, et al.
Front Biosci (Landmark Ed) . 2024 Jul; 29(7):264. PMID: 39082355
Background: The ability to maintain muscle function decreases with age and loss of proteostatic function. Diet, drugs, and genetic interventions that restrict nutrients or nutrient signaling help preserve long-term muscle...
4.
Snow S, Mir D, Ma Z, Horrocks J, Cox M, Ruzga M, et al.
bioRxiv . 2024 Apr; PMID: 38559178
Background: The ability to maintain muscle function decreases with age and loss of proteostatic function. Diet, drugs, and genetic interventions that restrict nutrients or nutrient signaling help preserve long-term muscle...
5.
Mir D, Cox M, Horrocks J, Ma Z, Rogers A
bioRxiv . 2024 Feb; PMID: 38370756
Dietary restriction (DR) mitigates loss of proteostasis associated with aging that underlies neurodegenerative conditions including Alzheimer's disease and related dementias. Previously, we observed increased translational efficiency of certain FMRFamide-like neuropeptide...
6.
He L, Zhang M, Cox M, Zhang Q, Donnell A, Zhang Y, et al.
ACS Med Chem Lett . 2024 Feb; 15(2):189-196. PMID: 38352849
Small molecule toll-like receptor (TLR) 7 agonists have gathered considerable interest as promising therapeutic agents for applications in cancer immunotherapy. Herein, we describe the development and optimization of a series...
7.
Poudel Y, He L, Cox M, Zhang Q, Johnson W, Cong Q, et al.
ACS Med Chem Lett . 2024 Feb; 15(2):181-188. PMID: 38352830
We have designed and developed novel and selective TLR7 agonists that exhibited potent receptor activity in a cell-based reporter assay. , these agonists significantly induced secretion of cytokines IL-6, IL-1β,...
8.
Ma Z, Horrocks J, Mir D, Cox M, Ruzga M, Rollins J, et al.
Front Cell Dev Biol . 2024 Jan; 11:1263344. PMID: 38161330
The highly conserved integrated stress response (ISR) reduces and redirects mRNA translation in response to certain forms of stress and nutrient limitation. It is activated when kinases phosphorylate a key...
9.
Luo H, Li Y, Robbins D, Wang S, Xi G, Cox M, et al.
Biotechnol Prog . 2020 Dec; 37(3):e3119. PMID: 33373106
Process-related impurities (PRIs) derived from manufacturing process should be minimized in final drug product. ICH Q3A provides a regulatory road map for PRIs but excludes biologic drugs like monoclonal antibodies...
10.
Knights H, Mayor N, Millar K, Cox M, Bunova E, Hughes M, et al.
Clin Med (Lond) . 2020 Jul; 20(5):e148-e153. PMID: 32709637
Background: This retrospective cohort study aims to define the clinical findings and outcomes of every patient admitted to a district general hospital in Surrey with COVID-19 in March 2020, providing...